Journal Guide

Biomacromolecules is the leading forum for the dissemination of cutting-edge research at the interface of polymer science and biology. Submissions to Biomacromolecules should contain strong elements of innovation in terms of macromolecular design, synthesis and characterization, or in the application of polymer materials to biology and medicine.

Topics covered by Biomacromolecules include, but are not exclusively limited to:

• Sustainable polymers
• Natural and renewable polymers
• Chitin, chitosan, lignin, tannin, and polyaromatic polymers
• Degradable and recyclable polymers
• Polymer conjugates
• Polymeric drugs
• Polymers in biocatalysis
• Biomacromolecular assembly
• Biomimetic polymers
• Polymer-biomineral hybrids
• Bioactive polymer surfaces
• Original polymer design for biomedical applications
• Polymers in tissue engineering and regenerative medicine
• Polymeric scaffolds
• Hydrogels for cell culture and delivery

drug discovery, imaging, therapeutic intervention, personalised medicine

The journal Biomarkers brings together all aspects of the rapidly growing field of biomarker research, encompassing their various uses and applications in one essential source.The journal has enlarged its scope to include the expanding area of biomarkers of disease and now intends to include evidence-based pharmacodynamic markers. Biomarkers, now more than ever, provides a vital forum for the exchange of ideas and techniques in all areas of biomarker research. High quality papers in four main areas are accepted and manuscripts describing novel biomarkers and their subsequent validation are especially encouraged:*Biomarkers of disease: covering measurement of endogenous substances or parameters indicative of a disease process and the use of pharmacodynamic and genetic markers in evidence-based laboratory medicine and treatment (markers of efficacy);* Biomarkers of exposure: covering detection and measurement of internal exposure to drugs and other chemicals;*Biomarkers of response: including measures of endogenous substances or parameters indicative of pathological or biochemical changes both toxicodynamic and pharmacodynamic, resulting from exposure to drugs and other chemicals;*Biomarkers of susceptibility: including genetic factors which alter susceptibility to drugs and other chemicals.Manuscripts can describe biomarkers measured in humans or other animals in vivo or in vitro. Biomarkers will consider publishing negative data from studies of biomarkers of susceptibility in human populations.The emphasis will be on demonstrating relationships between markers and effects rather than methodological papers unless they describe novel techniques.Read More: http://informahealthcare.com/page/bmk/Description.

Biomarkers in Medicine is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice. As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.

Biomass and Bioenergy is an international journal publishing original research papers and short communications, review articles and case studies on biological resources, chemical and biological processes, and biomass products for new renewable sources of energy and materials.The scope of the journal extends to the environmental, management and economic aspects of biomass and bioenergy.Key areas covered by the journal:• Biomass: sources, energy crop production processes, genetic improvements, composition. Please note that research on these biomass subjects must be linked directly to bioenergy generation.• Biological Residues: residues/rests from agricultural production, forestry and plantations (palm, sugar etc), processing industries, and municipal sources (MSW). Papers on the use of biomass residues through innovative processes/technological novelty and/or consideration of feedstock/system sustainability (or unsustainability) are welcomed. However waste treatment processes and pollution control or mitigation which are only tangentially related to bioenergy are not in the scope of the journal, as they are more suited to publications in the environmental arena. Papers that describe conventional waste streams (ie well described in existing literature) that do not empirically address 'new' added value from the process are not suitable for submission to the journal.• Bioenergy Processes: fermentations, thermochemical conversions, liquid and gaseous fuels, and petrochemical substitutes• Bioenergy Utilization: direct combustion, gasification, electricity production, chemical processes, and by-product remediation• Biomass and the Environment: carbon cycle, the net energy efficiency of bioenergy systems, assessment of sustainability, and biodiversity issues.The journal does not accept for review papers on the following subjects:• Performance of fuel combustion in engines• Technical aspects of first generation biofuels• Soil science papers with no direct linking to bioenergy generation• Isolation of yeast/bacterial strains• Purely analytical biochemistry derived studies that have no direct linking to bioenergy generationBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.Click here for New Editorial Instructions.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

biomaterials, tissue engineering, regenerative medicine, drug delivery systems, nanomedicine, medical devices

Biomaterials Science is an international high impact journal exploring the science of biomaterials and their translation towards clinical use. Its scope encompasses new concepts in biomaterials design, studies into the interaction of biomaterials with the body, and the use of materials to answer fundamental biological questions. Papers do not necessarily need to report a new biomaterial but should provide novel insight into the biological applications of the biomaterial.